Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017

Mostrar otras versiones (1)

BACKGROUND: Malaria control is highly dependent on the effectiveness of artemisinin-based combination therapy (ACT), the current frontline malaria curative treatment. Unfortunately, the emergence and spread of parasites resistant to artemisinin (ART) derivatives in Southeast Asia and South America,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yade, Mamadou Samb, Dièye, Baba, Coppée, Romain, Mbaye, Aminata, Diallo, Mamadou Alpha, Diongue, Khadim, Bailly, Justine, Mama, Atikatou, Fall, Awa, Thiaw, Alphonse Birane, Ndiaye, Ibrahima Mbaye, Ndiaye, Tolla, Gaye, Amy, Tine, Abdoulaye, Diédhiou, Younouss, Mbaye, Amadou Mactar, Doderer-Lang, Cécile, Garba, Mamane Nassirou, Bei, Amy Kristine, Ménard, Didier, Ndiaye, Daouda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223908/
https://www.ncbi.nlm.nih.gov/pubmed/37237307
http://dx.doi.org/10.1186/s12936-023-04588-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223908/
https://www.ncbi.nlm.nih.gov/pubmed/37237307
http://dx.doi.org/10.1186/s12936-023-04588-1

Ejemplares similares